2024–2025
Suzhou Fuent Pharmaceutical Co., Ltd. conducted its Phase I clinical trial in China at Zhongshan Hospital of Fudan University, Peking University Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, Jiangsu Provincial People’s Hospital, and Zhejiang Cancer Hospital.
Learn More
